NCT02209376 · Interventional trial
Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma
Overall registry status Terminated
Phase 1
Conditions Patients With Residual or Reccurent EGFRvIII+ Glioma
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory